PRMT5 and hepatocellular carcinoma: For example, Luo and colleagues identified Prmt5, encoding protein arginine N-methyltransferase 5, as a key metabolic modulator of MYC-induced HCC; and by disrupting this pathway they could enhance the response to anti-PD-1 therapy163.